Patatin-domain-containing (phospho)lipases under control: Mammalian co-regulators and pathogenic activation mechanisms. [PDF]
Dubey N, Riegler-Berket L, Oberer M.
europepmc +1 more source
Enzymatic Degumming of Arachidonic Acid Oil Using Immobilized Phospholipase A1 on Hollow Double-Layer Mesoporous Silica Nanoparticles. [PDF]
Li X +8 more
europepmc +1 more source
Structural insights into Phospholipase Cε activity and regulation. [PDF]
Mahurkar KA +3 more
europepmc +1 more source
Unprovoked Pulmonary Embolism with Bilateral Deep Vein Thrombosis Revealing Occult Nephrotic Syndrome Due to Seronegative Membranous Nephropathy. [PDF]
Eser S, Serra A, Kleber M, Brombacher F.
europepmc +1 more source
The Inhibitory Effects of Zinc Oxide Nanoparticles on Clinical Isolates of Malassezia in Dogs. [PDF]
Vazifehdust A +5 more
europepmc +1 more source
Recombinant phospholipase A<sub>2</sub> inhibitor of <i>Sinonatrix annularis</i> (ringed water snake) attenuates hemorrhagic action of the venom from <i>Daboia siamensis</i> (Siamese Russell's viper). [PDF]
Thaveekarn W +3 more
europepmc +1 more source
Clinical profile and outcome of primary membranous nephropathy: A tertiary care center experience from North India. [PDF]
Wani MA +7 more
europepmc +1 more source
Diagnostic Accuracy of Serum Anti-phospholipase A2 Receptor (PLA2R) Antibody Assays for Membranous Nephropathy in Patients With Nephrotic Syndrome: A Systematic Review. [PDF]
Hamad S +5 more
europepmc +1 more source
Reconsideration of Response Assessment in Obinutuzumab-Treated Membranous Nephropathy. [PDF]
Atay İ, Eröz E, Heybeli C.
europepmc +1 more source
A novel approach to combat <i>Pseudomonas aeruginosa</i>: repurposing pharmaceuticals for inhibition of phospholipase A. [PDF]
Modric M +7 more
europepmc +1 more source

